LPTH: tiny defense optics player chasing a big backlog

The thesis

LightPath (LPTH) is turning into a focused defense‑imaging supplier with real numbers behind the story. In fiscal Q3 2026, revenue jumped to $19.1M, up 109% from last year, and gross profit climbed 161% to $7.0M, with margins improving to 36%. Their order backlog hit about $110.6M, up roughly 196% since the fiscal year started, giving decent visibility for future sales. The Amorphous Materials deal in January 2026 adds large‑diameter infrared glass, while the earlier G5 Infrared camera acquisition is showing up in growing camera and module sales. Management is talking about a long‑term goal of over $300M revenue in five years and has raised roughly $50–100M through stock offerings around $14 per share to fund that growth.[2][1][4]

Everyone wishes they'd bought Nvidia early. Here's how to spot the next one.

The biggest winners of the last decade had one thing in common. Our data follows those exact moves — and turns them into 10 names to watch right now.

The big names in the AI, Space, Nuclear and Robotics race. The window to get in early is closing fast. Don't wait.

See the top 10 stocks now — free ›

💡 Why this matters

If you care about the rise in defense tech—smart missiles, night vision, border security, drones—LightPath sits in the plumbing of that trend. They make the specialized lenses and infrared cameras that help soldiers and systems “see” in the dark and through smoke. As governments boost spending on high‑tech gear, suppliers that can reliably deliver these parts can grow for years. You’re not betting on one gadget; you’re betting on a picks‑and‑shovels player behind modern defense imaging.[2][1][7]

▲ Catalysts

+ Q4 FY26 earnings later in 2026: watch if revenue keeps compounding and backlog stays above $100M.[2][5]
+ Integration of Amorphous Materials from January 2026, adding big infrared glass capacity to support larger defense optics.[1]
+ Defense infrared camera orders, including multi‑million‑dollar deals with U.S. programs, could expand into repeat buys.[6]
+ Fresh capital from 2026 stock offerings around $14/share gives cash to scale factories and win bigger contracts.[4][1]
+ New senior sales leaders with defense backgrounds hired in 2026 to deepen relationships with major military customers.[4]

▼ Risks

! Company is still losing money; if growth slows, more stock sales could dilute existing shareholders.[1][2][4]
! Business leans heavily on defense orders; delays or cuts in military budgets could hit revenue hard.[2][6]
! Stock is up over 300% in a year, so expectations are high and any stumble could mean a sharp pullback.[4]
! Small size versus big rivals; larger optics players could compete hard on price or grab key programs.[7]

🎯 One thing to take away

LightPath is a small company trying to become a go‑to supplier of “eyes” for modern defense gear—infrared lenses and cameras that let systems see in the dark. The numbers in 2026 are eye‑catching: triple‑digit revenue growth, better margins, and a backlog of work that’s now bigger than the whole business used to be. They’ve bought two niche businesses to expand what they can make and raised cash to build out capacity, but they still lose money and the share count has climbed. If you’re curious about a higher‑risk, defense‑growth name with real momentum but plenty that can go wrong, LPTH is worth a closer look and some digging into their investor materials.[2][1][4][7]

Data sources & methodology

All figures derive from official, public-domain government filings. Read our methodology for how we collect, process and score this data. See the methodology →

TZ Researched & published by TradesZ Research

Want our premium picks too?

Pro subscribers get our strongest pre-pop ideas + real-time buy-zone alerts.

Thinking about LPTH?

Our data likes 10 other stocks even more right now — under-the-radar names we believe have monster upside potential. Get the free list before the crowd catches on.

Show me the 10 stocks — free →

Free · no credit card · unsubscribe in one click

Not investment advice. We share research and analyses for educational purposes. Investing in stocks involves risk, including possible loss of capital. Always do your own research.